In Practise Logo
In Practise Logo - Blue
In Practise Logo
IP Interview
Published September 6, 2024

Bonesupport: CERAMENT, Bone Infections & Use Cases

Executive Bio

Former Sales Manager at Bonesupport

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

Why is the addition of the second material so important?

The results from studies and clinical reports show that calcium sulfate is reabsorbed by the body quite quickly. The inventors of CERAMENT believed that to aid bone cell growth, the addition of hydroxyapatite would be beneficial. Hydroxyapatite acts as a scaffold inside the body, providing a structure for the growing bone cells to use, leading to more solid and complete bone regeneration.

This is a snippet of the transcript.to get full access.

Yes, that makes sense. If we think about the type of physician that uses CERAMENT, is it just orthopedic surgeons? Who are the key users of CERAMENT?

However, literature indicates that only 10% of the total antibiotic administered reached the bone infection, making it very ineffective. This meant that after four to six months, patients often returned with recurring bone infections. Even a small piece of infected bone left untreated could lead to bacterial colonization and reinfection. It was a nightmare for surgeons to deal with patients with bone infections, which often worsened over time, sometimes leading to amputations. It was a very complex problem with very complex patients.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.